CD8A and neoplasm: In this study, we have used a combination of tumor whole exome sequencing, transcriptomics (RNA-seq), seromics (auto-antibody identification using protein arrays), and identification of MHC-associated peptides (MAPs) by mass-spectrometry to perform an integrated analysis of the antigen specificities of CD8+ TILs from HGSC patients.